APRE Stock Price Prediction 2026-2027
AI-powered forecast for Aprea Therapeutics Inc
Based on Wall Street consensus estimate - Medium Confidence
Current Price
$0.88
Price Targets for 2027
Bear Case
$5.95
+579.5%
Base Case
$7.00
+699.5%
Bull Case
$8.05
+819.4%
Prediction Tracking
Coming Soon for APRE
Tracking begins January 2026
We are building a comprehensive track record of our AI predictions. Check back to see how our forecasts perform against actual results.
Upcoming Events for APRE
Key Factors Influencing APRE Stock
Bullish Factors
- Significant upside potential to bull case target
- Market position and competitive advantages
Risk Factors
- Declining revenue growth of -1.0%
- Market volatility and macroeconomic factors
- Competitive pressures in Biotechnology
Prediction Methodology
These predictions are based on the Wall Street consensus price target of $7.00.
Bull and bear cases are calculated with a reasonable spread around the consensus based on historical volatility.
Get Real-Time Analysis
Access live data, AI insights, and detailed valuations for APRE
Frequently Asked Questions
What is APRE stock price today?
APRE (Aprea Therapeutics Inc) stock is trading at $0.88 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is APRE stock going up or down today?
APRE stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy APRE stock now?
The decision to buy APRE depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is APRE a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for APRE based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is APRE stock overvalued or undervalued?
Use our DCF valuation calculator to determine if APRE is overvalued or undervalued based on fundamental analysis and future cash flow projections.
What is APRE's P/E ratio?
P/E ratio data for APRE will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.
What is APRE's market cap?
APRE (Aprea Therapeutics Inc) has a market capitalization of $0.01 billion, making it a small-cap stock.
What is APRE's price to book ratio?
APRE trades at a price-to-book (P/B) ratio of 0.57, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Does APRE pay dividends?
APRE does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.
What is APRE's dividend yield?
APRE does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.
Is APRE stock a good long-term investment?
APRE's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.
What is APRE's revenue growth rate?
APRE has shown revenue growth of -1.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.
Is APRE profitable?
Profitability metrics for APRE are available on our dashboard with complete income statement analysis.
What are the risks of investing in APRE?
Key risks for APRE include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.
How does APRE compare to its competitors?
Compare APRE to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize APRE's performance and positioning.
What is APRE's stock price target for 2026?
Our AI model provides price targets for APRE based on fundamental analysis: Bull case $1.14 (+30%), Base case $1.01 (+15%), Bear case $0.79 (-10%). Visit our prediction page for detailed forecasts.
What do analysts say about APRE?
Wall Street analysts provide ratings (buy/hold/sell) and price targets for APRE. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.
When is APRE's next earnings report?
APRE reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.